Alpha Cognition (XCNQ:ACOG) Other Long-Term Liabilities : C$1.53 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Other Long-Term Liabilities?

Alpha Cognition's other long-term liabilities for the quarter that ended in Mar. 2024 was C$1.53 Mil.

Alpha Cognition's quarterly other long-term liabilities declined from Sep. 2023 (C$6.69 Mil) to Dec. 2023 (C$6.09 Mil) and declined from Dec. 2023 (C$6.09 Mil) to Mar. 2024 (C$1.53 Mil).

Alpha Cognition's annual other long-term liabilities declined from Dec. 2021 (C$2.62 Mil) to Dec. 2022 (C$0.29 Mil) but then increased from Dec. 2022 (C$0.29 Mil) to Dec. 2023 (C$6.09 Mil).

Alpha Cognition Other Long-Term Liabilities Historical Data

The historical data trend for Alpha Cognition's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Other Long-Term Liabilities Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial										-	-	-	-	-

Alpha Cognition Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Alpha Cognition Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Cognition (XCNQ:ACOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (XCNQ:ACOG) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

ACOGF:USA

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.

Alpha Cognition (XCNQ:ACOG) Headlines

No Headlines